scispace - formally typeset
K

Katherine S. Lovejoy

Researcher at Los Alamos National Laboratory

Publications -  28
Citations -  2641

Katherine S. Lovejoy is an academic researcher from Los Alamos National Laboratory. The author has contributed to research in topics: Ionic liquid & Cisplatin. The author has an hindex of 17, co-authored 28 publications receiving 2421 citations. Previous affiliations of Katherine S. Lovejoy include IBM & Thermo Fisher Scientific.

Papers
More filters
Journal ArticleDOI

Organic cation transporters are determinants of oxaliplatin cytotoxicity.

TL;DR: The results indicate that OCT1 and OCT2 are major determinants of the anticancer activity of oxaliplatin and may contribute to its antitumor specificity and strongly suggest that expression of OCTs in tumors should be investigated as markers for selecting specific platinum-based therapies in individual patients.
Journal ArticleDOI

Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing.

TL;DR: A molecular platform for dual-function fluorescence/MRI sensing of mobile zinc with strategically attached porphyrin template is reported, anticipating that in vivo applications of the probes will facilitate a deeper understanding of the physiological roles of zinc and allow detection of abnormal zinc homeostasis for pathological diagnoses.
Journal ArticleDOI

Ionic liquids as a class of materials for transdermal delivery and pathogen neutralization

TL;DR: This work establishes the use of ILs for simultaneous enhancement of topical drug delivery and antibiotic activity, and choline-geranate emerged as a multipurpose IL with excellent antimicrobial activity, minimal toxicity to epithelial cells as well as skin, and effective permeation enhancement for drug delivery.
Journal ArticleDOI

cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects

TL;DR: Unique chemical and biological properties of a cationic monofunctional platinum(II) complex, cis-diammine(pyridine)chloroplatinum(II), cis-[Pt(NH3)2(py)Cl]+ or cDPCP, a coordination compound previously identified to have significant anticancer activity in a mouse tumor model, merit consideration for treating colorectal and other cancers bearing appropriate cation transporters.